A double-blind, randomized, multi-center study followed by 12 months open-label treatment to evaluate the dose response and safety of valsartan in pediatric hypertensive patients
Latest Information Update: 16 Nov 2011
At a glance
- Drugs Valsartan (Primary)
- Indications Hypertension
- Focus Therapeutic Use
- 07 Nov 2011 Actual end date (Mar 2006) added as reported by ClinicalTrials.gov.
- 13 Nov 2005 New trial record.